NICE guideline on antibiotics for pneumonia. The aim is to ensure the best antibiotic management of suspected or confirmed bacterial pneumonia in adults in hospital during the COVID‑19 pandemic. This includes people presenting to hospital with moderate to severe community-acquired pneumonia and people who develop pneumonia while in hospital. Evidence so far suggests that bacterial co-infection occurs in less than about 10% of patients with COVID‑19. If there is confidence that the clinical features are typical for COVID‑19, it is reasonable not to start empirical antibiotics. Empirical antibiotics however should be started if there is clinical suspicion of bacterial infection, including characteristic symptoms and localised chest findings.